 | • レポートコード：MRC2-11QY06726 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はG-CSF・G-CSFバイオシミラーのグローバル市場について調査・分析したレポートです。種類別（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症）市場規模、用途別（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別G-CSF・G-CSFバイオシミラーの競争状況、市場シェア ・世界のG-CSF・G-CSFバイオシミラー市場：種類別市場規模 2015年-2020年（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症） ・世界のG-CSF・G-CSFバイオシミラー市場：種類別市場規模予測 2021年-2026年（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症） ・世界のG-CSF・G-CSFバイオシミラー市場：用途別市場規模 2015年-2020年（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン） ・世界のG-CSF・G-CSFバイオシミラー市場：用途別市場規模予測 2021年-2026年（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン） ・北米のG-CSF・G-CSFバイオシミラー市場分析：米国、カナダ ・ヨーロッパのG-CSF・G-CSFバイオシミラー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのG-CSF・G-CSFバイオシミラー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のG-CSF・G-CSFバイオシミラー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのG-CSF・G-CSFバイオシミラー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis、Roche、Merck & Co.、Sanofi、Johnson & Johnson、Gilead Science、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca、Bayer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
Market Analysis and Insights: Global G-CSF and G-CSF Biosimilars Market
The global G-CSF and G-CSF Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global G-CSF and G-CSF Biosimilars Scope and Market Size
G-CSF and G-CSF Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global G-CSF and G-CSF Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the G-CSF and G-CSF Biosimilars market is segmented into
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Segment by Application, the G-CSF and G-CSF Biosimilars market is segmented into
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Regional and Country-level Analysis
The G-CSF and G-CSF Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the G-CSF and G-CSF Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and G-CSF and G-CSF Biosimilars Market Share Analysis
G-CSF and G-CSF Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in G-CSF and G-CSF Biosimilars business, the date to enter into the G-CSF and G-CSF Biosimilars market, G-CSF and G-CSF Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
1 Study Coverage
1.1 G-CSF and G-CSF Biosimilars Product Introduction
1.2 Market Segments
1.3 Key G-CSF and G-CSF Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type
1.4.2 Blood Disorders
1.4.3 Oncology Diseases
1.4.4 Chronic And Autoimmune Diseases
1.4.5 Growth Hormone Deficiencies
1.5 Market by Application
1.5.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application
1.5.2 Human Growth Hormone
1.5.3 Erythropoietin
1.5.4 Monoclonal Antibodies
1.5.5 Insulin
1.5.6 Interferon
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global G-CSF and G-CSF Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global G-CSF and G-CSF Biosimilars Revenue 2015-2026
2.1.2 Global G-CSF and G-CSF Biosimilars Sales 2015-2026
2.2 Global G-CSF and G-CSF Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global G-CSF and G-CSF Biosimilars Competitor Landscape by Players
3.1 G-CSF and G-CSF Biosimilars Sales by Manufacturers
3.1.1 G-CSF and G-CSF Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 G-CSF and G-CSF Biosimilars Revenue by Manufacturers
3.2.1 G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global G-CSF and G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by G-CSF and G-CSF Biosimilars Revenue in 2019
3.2.5 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 G-CSF and G-CSF Biosimilars Price by Manufacturers
3.4 G-CSF and G-CSF Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 G-CSF and G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers G-CSF and G-CSF Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global G-CSF and G-CSF Biosimilars Market Size by Type (2015-2020)
4.1.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2015-2020)
4.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Type (2015-2020)
4.1.3 G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global G-CSF and G-CSF Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 G-CSF and G-CSF Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global G-CSF and G-CSF Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global G-CSF and G-CSF Biosimilars Market Size by Application (2015-2020)
5.1.1 Global G-CSF and G-CSF Biosimilars Sales by Application (2015-2020)
5.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Application (2015-2020)
5.1.3 G-CSF and G-CSF Biosimilars Price by Application (2015-2020)
5.2 G-CSF and G-CSF Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global G-CSF and G-CSF Biosimilars Price Forecast by Application (2021-2026)
6 North America
6.1 North America G-CSF and G-CSF Biosimilars by Country
6.1.1 North America G-CSF and G-CSF Biosimilars Sales by Country
6.1.2 North America G-CSF and G-CSF Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Type
6.3 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Application
7 Europe
7.1 Europe G-CSF and G-CSF Biosimilars by Country
7.1.1 Europe G-CSF and G-CSF Biosimilars Sales by Country
7.1.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Type
7.3 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific G-CSF and G-CSF Biosimilars by Region
8.1.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region
8.1.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Application
9 Latin America
9.1 Latin America G-CSF and G-CSF Biosimilars by Country
9.1.1 Latin America G-CSF and G-CSF Biosimilars Sales by Country
9.1.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America G-CSF and G-CSF Biosimilars Market Facts & Figures by Type
9.3 Central & South America G-CSF and G-CSF Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa G-CSF and G-CSF Biosimilars by Country
10.1.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country
10.1.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis G-CSF and G-CSF Biosimilars Products Offered
11.2.5 Novartis Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche G-CSF and G-CSF Biosimilars Products Offered
11.3.5 Roche Related Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Description and Business Overview
11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Products Offered
11.4.5 Merck & Co. Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi G-CSF and G-CSF Biosimilars Products Offered
11.5.5 Sanofi Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Gilead Science
11.7.1 Gilead Science Corporation Information
11.7.2 Gilead Science Description and Business Overview
11.7.3 Gilead Science Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Science G-CSF and G-CSF Biosimilars Products Offered
11.7.5 Gilead Science Related Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description and Business Overview
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Products Offered
11.8.5 GlaxoSmithKline Related Developments
11.9 AbbVie
11.9.1 AbbVie Corporation Information
11.9.2 AbbVie Description and Business Overview
11.9.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AbbVie G-CSF and G-CSF Biosimilars Products Offered
11.9.5 AbbVie Related Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Description and Business Overview
11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Amgen G-CSF and G-CSF Biosimilars Products Offered
11.10.5 Amgen Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
11.1.5 Pfizer Related Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description and Business Overview
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Region
12.1.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America G-CSF and G-CSF Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: G-CSF and G-CSF Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: G-CSF and G-CSF Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: G-CSF and G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe G-CSF and G-CSF Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: G-CSF and G-CSF Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: G-CSF and G-CSF Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: G-CSF and G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific G-CSF and G-CSF Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: G-CSF and G-CSF Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: G-CSF and G-CSF Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: G-CSF and G-CSF Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America G-CSF and G-CSF Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: G-CSF and G-CSF Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: G-CSF and G-CSF Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: G-CSF and G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: G-CSF and G-CSF Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: G-CSF and G-CSF Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: G-CSF and G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key G-CSF and G-CSF Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 G-CSF and G-CSF Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. G-CSF and G-CSF Biosimilars Market Segments
Table 2. Ranking of Global Top G-CSF and G-CSF Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Blood Disorders
Table 5. Major Manufacturers of Oncology Diseases
Table 6. Major Manufacturers of Chronic And Autoimmune Diseases
Table 7. Major Manufacturers of Growth Hormone Deficiencies
Table 8. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global G-CSF and G-CSF Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global G-CSF and G-CSF Biosimilars Sales by Regions 2015-2020 (K Units)
Table 11. Global G-CSF and G-CSF Biosimilars Sales Market Share by Regions (2015-2020)
Table 12. Global G-CSF and G-CSF Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global G-CSF and G-CSF Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturers (2015-2020)
Table 15. Global G-CSF and G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global G-CSF and G-CSF Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2019)
Table 17. G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers G-CSF and G-CSF Biosimilars Price (2015-2020) (USD/Unit)
Table 20. G-CSF and G-CSF Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers G-CSF and G-CSF Biosimilars Product Type
Table 22. Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 25. Global G-CSF and G-CSF Biosimilars Sales Share by Type (2015-2020)
Table 26. Global G-CSF and G-CSF Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 27. Global G-CSF and G-CSF Biosimilars Revenue Share by Type (2015-2020)
Table 28. G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 30. Global G-CSF and G-CSF Biosimilars Sales Share by Application (2015-2020)
Table 31. North America G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 32. North America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 33. North America G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 34. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 35. North America G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 36. North America G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 37. North America G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 38. North America G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 39. Europe G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 40. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 41. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 43. Europe G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 44. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 45. Europe G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 46. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 55. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 56. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 59. Latin America G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 60. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 61. Latin America G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 62. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. Roche Corporation Information
Table 82. Roche Description and Major Businesses
Table 83. Roche G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Roche Product
Table 85. Roche Recent Development
Table 86. Merck & Co. Corporation Information
Table 87. Merck & Co. Description and Major Businesses
Table 88. Merck & Co. G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Merck & Co. Product
Table 90. Merck & Co. Recent Development
Table 91. Sanofi Corporation Information
Table 92. Sanofi Description and Major Businesses
Table 93. Sanofi G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Sanofi Product
Table 95. Sanofi Recent Development
Table 96. Johnson & Johnson Corporation Information
Table 97. Johnson & Johnson Description and Major Businesses
Table 98. Johnson & Johnson G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Johnson & Johnson Product
Table 100. Johnson & Johnson Recent Development
Table 101. Gilead Science Corporation Information
Table 102. Gilead Science Description and Major Businesses
Table 103. Gilead Science G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Gilead Science Product
Table 105. Gilead Science Recent Development
Table 106. GlaxoSmithKline Corporation Information
Table 107. GlaxoSmithKline Description and Major Businesses
Table 108. GlaxoSmithKline G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. GlaxoSmithKline Product
Table 110. GlaxoSmithKline Recent Development
Table 111. AbbVie Corporation Information
Table 112. AbbVie Description and Major Businesses
Table 113. AbbVie G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. AbbVie Product
Table 115. AbbVie Recent Development
Table 116. Amgen Corporation Information
Table 117. Amgen Description and Major Businesses
Table 118. Amgen G-CSF and G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Amgen Product
Table 120. Amgen Recent Development
Table 121. AstraZeneca Corporation Information
Table 122. AstraZeneca Description and Major Businesses
Table 123. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. AstraZeneca Product
Table 125. AstraZeneca Recent Development
Table 126. Bayer Corporation Information
Table 127. Bayer Description and Major Businesses
Table 128. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Bayer Product
Table 130. Bayer Recent Development
Table 131. Global G-CSF and G-CSF Biosimilars Sales Forecast by Regions (2021-2026) (K Units)
Table 132. Global G-CSF and G-CSF Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global G-CSF and G-CSF Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global G-CSF and G-CSF Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: G-CSF and G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 136. North America: G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: G-CSF and G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 138. Europe: G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: G-CSF and G-CSF Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 140. Asia Pacific: G-CSF and G-CSF Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: G-CSF and G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 142. Latin America: G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: G-CSF and G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 144. Middle East and Africa: G-CSF and G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key G-CSF and G-CSF Biosimilars Players
Table 149. G-CSF and G-CSF Biosimilars Customers List
Table 150. G-CSF and G-CSF Biosimilars Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. G-CSF and G-CSF Biosimilars Product Picture
Figure 2. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Blood Disorders Product Picture
Figure 4. Oncology Diseases Product Picture
Figure 5. Chronic And Autoimmune Diseases Product Picture
Figure 6. Growth Hormone Deficiencies Product Picture
Figure 7. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 8. Human Growth Hormone
Figure 9. Erythropoietin
Figure 10. Monoclonal Antibodies
Figure 11. Insulin
Figure 12. Interferon
Figure 13. G-CSF and G-CSF Biosimilars Report Years Considered
Figure 14. Global G-CSF and G-CSF Biosimilars Market Size 2015-2026 (US$ Million)
Figure 15. Global G-CSF and G-CSF Biosimilars Sales 2015-2026 (K Units)
Figure 16. Global G-CSF and G-CSF Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Figure 18. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 19. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Figure 20. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 21. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by G-CSF and G-CSF Biosimilars Revenue in 2019
Figure 23. G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Figure 25. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2019
Figure 26. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2015-2020)
Figure 27. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type in 2019
Figure 28. Global G-CSF and G-CSF Biosimilars Market Share by Price Range (2015-2020)
Figure 29. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Figure 30. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application in 2019
Figure 31. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2015-2020)
Figure 32. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application in 2019
Figure 33. North America G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 36. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 37. U.S. G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America G-CSF and G-CSF Biosimilars Market Share by Type in 2019
Figure 42. North America G-CSF and G-CSF Biosimilars Market Share by Application in 2019
Figure 43. Europe G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 46. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 47. Germany G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 50. France G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe G-CSF and G-CSF Biosimilars Market Share by Type in 2019
Figure 58. Europe G-CSF and G-CSF Biosimilars Market Share by Application in 2019
Figure 59. Asia Pacific G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 62. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 63. China G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 64. China G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 70. India G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific G-CSF and G-CSF Biosimilars Market Share by Type in 2019
Figure 86. Asia Pacific G-CSF and G-CSF Biosimilars Market Share by Application in 2019
Figure 87. Latin America G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 90. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 91. Mexico G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America G-CSF and G-CSF Biosimilars Market Share by Type in 2019
Figure 98. Latin America G-CSF and G-CSF Biosimilars Market Share by Application in 2019
Figure 99. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 102. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 103. Turkey G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa G-CSF and G-CSF Biosimilars Market Share by Type in 2019
Figure 110. Middle East and Africa G-CSF and G-CSF Biosimilars Market Share by Application in 2019
Figure 111. North America G-CSF and G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America G-CSF and G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe G-CSF and G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe G-CSF and G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific G-CSF and G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America G-CSF and G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America G-CSF and G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
G-CSFバイオシミラーの世界市場（～2026年） Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- HGHバイオシミラーの世界市場（～2026年） HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection…
- 生物製剤・バイオシミラーの世界市場（～2026年） Market Analysis and Insights: Global Biologics & Biosimilars Market The global Biologics & Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biologics & Biosimilars Scope and Market Size Biologics & Biosimila…